drugset / Trial / NCT06751290
The Use of Cyproheptadine in Pediatric Feeding Disorders
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The goal of this clinical trial is to learn if Cyproheptadine, an appetite stimulant, can improve eating habits in children with Pediatric Feeding Disorders. Pediatric Feeding Disorders is a broad term that describes disorders of eating-related behaviors that causes altered consumption of food and impairs physical or psychosocial health.
Timeline
- Start
- 2024-12-30
- Primary completion
- 2026-04-30
- Completion
- 2026-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyproheptadine | Small molecule | 0.25 mg/kg | Oral |